150 related articles for article (PubMed ID: 23601218)
1. Phosphorylated mammalian target of rapamycin is associated with an adverse outcome in oral squamous cell carcinoma.
Monteiro LS; Delgado ML; Ricardo S; Garcez F; do Amaral B; Warnakulasuriya S; Lopes C
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 May; 115(5):638-45. PubMed ID: 23601218
[TBL] [Abstract][Full Text] [Related]
2. High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma.
Moura IM; Delgado ML; Silva PM; Lopes CA; do Amaral JB; Monteiro LS; Bousbaa H
J Oral Pathol Med; 2014 Mar; 43(3):225-31. PubMed ID: 24044615
[TBL] [Abstract][Full Text] [Related]
3. Significance of nuclear p-mTOR expression in advanced oral squamous cell carcinoma with extracapsular extension of lymph node metastases.
Chen TC; Wu CT; Wang CP; Yang TL; Lou PJ; Ko JY; Chang YL
Oral Oncol; 2015 May; 51(5):493-9. PubMed ID: 25769791
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated ribosomal protein S6 correlation with p21 expression and inverse association with tumor size in oral squamous cell carcinoma.
de Vicente JC; Peña I; Rodrigo JP; Rodríguez-Santamarta T; Lequerica-Fernández P; Suárez-Fernández L; Allonca E; García-Pedrero JM
Head Neck; 2017 Sep; 39(9):1876-1887. PubMed ID: 28675642
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical characterization of the mTOR pathway in stage-I non-small-cell lung carcinoma.
Shin E; Choi CM; Kim HR; Jang SJ; Park YS
Lung Cancer; 2015 Jul; 89(1):13-8. PubMed ID: 25936472
[TBL] [Abstract][Full Text] [Related]
6. High mTOR expression is associated with a worse oncological outcome in laryngeal carcinoma treated with postoperative radiotherapy: a pilot study.
Lionello M; Blandamura S; Loreggian L; Ottaviano G; Giacomelli L; Marchese-Ragona R; Velardita C; Staffieri A; Marioni G
J Oral Pathol Med; 2012 Feb; 41(2):136-40. PubMed ID: 21943204
[TBL] [Abstract][Full Text] [Related]
7. Expression of the mammalian target of rapamycin pathway markers in lung adenocarcinoma and squamous cell carcinoma.
Kim HS; Kim GY; Lim SJ; Kim YW
Pathobiology; 2012; 79(2):84-93. PubMed ID: 22286903
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylated signal transducer and activator of transcription-1 immunohistochemical expression is associated with improved survival in patients with oral squamous cell carcinoma.
Pappa E; Nikitakis N; Vlachodimitropoulos D; Avgoustidis D; Oktseloglou V; Papadogeorgakis N
J Oral Maxillofac Surg; 2014 Jan; 72(1):211-21. PubMed ID: 23992782
[TBL] [Abstract][Full Text] [Related]
9. Expression of molecular markers associated with the mammalian target of rapamycin pathway in nonmetastatic renal cell carcinoma: Effect on prognostic outcomes following radical nephrectomy.
Nishikawa M; Miyake H; Harada K; Fujisawa M
Urol Oncol; 2014 Jan; 32(1):49.e15-21. PubMed ID: 24239474
[TBL] [Abstract][Full Text] [Related]
10. Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck.
Clauditz TS; Wang CJ; Gontarewicz A; Blessmann M; Tennstedt P; Borgmann K; Tribius S; Sauter G; Dalchow C; Knecht R; Münscher A; Wilczak W
J Oral Pathol Med; 2013 Feb; 42(2):125-32. PubMed ID: 22643116
[TBL] [Abstract][Full Text] [Related]
11. p-mTOR expression is associated with better prognosis in luminal breast carcinoma.
Beca F; Andre R; Martins DS; Bilhim T; Martins D; Schmitt F
J Clin Pathol; 2014 Nov; 67(11):961-7. PubMed ID: 25053543
[TBL] [Abstract][Full Text] [Related]
12. Comparative outcomes in oral cavity cancer with resected pT4a and pT4b.
Liao CT; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Ng SH; Lin CH; Tsao CK; Chen IH; Chang KP; Huang SF; Kang CJ; Fang KH; Wang YC; Chang YL; Huang YC; Tsai CY; Yen TC
Oral Oncol; 2013 Mar; 49(3):230-6. PubMed ID: 23063612
[TBL] [Abstract][Full Text] [Related]
13. Oral squamous cell carcinoma grading systems--analysis of the best survival predictor.
Lindenblatt Rde C; Martinez GL; Silva LE; Faria PS; Camisasca DR; Lourenço Sde Q
J Oral Pathol Med; 2012 Jan; 41(1):34-9. PubMed ID: 21902722
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of Ep-CAM protein is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Hwang EY; Yu CH; Cheng SJ; Chang JY; Chen HM; Chiang CP
J Oral Pathol Med; 2009 Jan; 38(1):87-93. PubMed ID: 18355175
[TBL] [Abstract][Full Text] [Related]
15. A 22 years survival and prognostic factors analysis in a homogeneous series of 64 patients with advanced cancer of the tongue and the floor of the mouth.
López-Cedrún JL; Andrés de Llano J
J Craniomaxillofac Surg; 2015 Apr; 43(3):376-81. PubMed ID: 25703504
[TBL] [Abstract][Full Text] [Related]
16. Divergence of P53, PTEN, PI3K, Akt and mTOR expression in tonsillar cancer.
Head Neck; ; . PubMed ID: 24616007
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
